Au-modified ceria nanozyme prevents and treats hypoxia-induced pulmonary hypertension with greatly improved enzymatic activity and safety

Abstract Background Despite recent advances the prognosis of pulmonary hypertension remains poor and warrants novel therapeutic options. Extensive studies, including ours, have revealed that hypoxia-induced pulmonary hypertension is associated with high oxidative stress. Cerium oxide nanozyme or nan...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rui Xiao, Jia Liu, Lin Shi, Ting Zhang, Jie Liu, Shuyi Qiu, Matthieu Ruiz, Jocelyn Dupuis, Liping Zhu, Lin Wang, Zheng Wang, Qinghua Hu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-08-01
coleção:	Journal of Nanobiotechnology
Assuntos:	Pulmonary hypertension Hypoxia CaSR Cerium oxide Au
Acesso em linha:	https://doi.org/10.1186/s12951-024-02738-4
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!